These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31625707)

  • 21. Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response.
    Belcaro G; Rohdewald P; Cesarone MR; Scipione C; Scipione V; Cornelli U; Luzzi R; Cotellese R; Dugall M; Hosoi M; Corsi M; Feragalli B
    Panminerva Med; 2022 Jun; 64(2):253-258. PubMed ID: 35815767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study.
    Belcaro G; Dugall M; Hosoi M; Feragalli B; Cotellese R; Saggino A; Cesarone MR; Ippolito E; Cornelli U; Ledda A; Cox DB
    J Neurosurg Sci; 2024 Feb; 68(1):109-116. PubMed ID: 38299491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
    Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
    Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.
    Belcaro G; Cesarone MR; Cornelli U; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Hosoi M; Maione C; Cotellese R; Cesinaro Di Rocco P
    Minerva Stomatol; 2019 Dec; 68(6):303-307. PubMed ID: 32052619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the combination Pycnogenol® and Centellicum® on preventing the progression of atherosclerotic plaques: a morphological study.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Cornelli U; Cotellese R; Dugall M; Hosoi M; Corsi M; Feragalli B; Cox D; Pizzicannella G
    Panminerva Med; 2023 Sep; 65(3):283-285. PubMed ID: 36789998
    [No Abstract]   [Full Text] [Related]  

  • 27. Postpartum stretchmarks: repairing activity of an oral Centella asiatica supplementation (Centellicum®).
    Hu S; Belcaro G; Hosoi M; Feragalli B; Luzzi R; Dugall M
    Minerva Ginecol; 2018 Oct; 70(5):629-634. PubMed ID: 30293400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary benign back pain: supplementation with Pycnogenol®.
    Cox D; Belcaro G; Cesarone MR; Cotellese R; Dugall M; Feragalli B; Hosoi M; Corsi M; Luzzi R
    Panminerva Med; 2021 Dec; 63(4):472-477. PubMed ID: 34915691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pycnogenol® + Centellicum® supplementation improves skin elasticity and microperfusion. Implication for surgical patients: a conceptual registry study.
    Cotellese R; Belcaro G; Hu S; Cesarone MR; Melchiorre E; Cornelli U; Feragalli B; Scipione C; Scipione V; Dugall M; Hosoi M; Corsi M
    Minerva Surg; 2024 Sep; ():. PubMed ID: 39259143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.
    Cesarone MR; Belcaro G; Hosoi M; Ledda A; Feragalli B; Maione C; Scipione C; Scipione V; Cotellese R; Hu S
    J Neurosurg Sci; 2020 Jun; 64(3):258-262. PubMed ID: 31957998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
    Belcaro G; Dugall M; Hu S; Feragalli B; Cotellese R; Ledda A; Corsi M; Ricci A; Ippolito E; Errichi BM; Cornelli U; Cesarone MR; Hosoi M
    Minerva Cardioangiol; 2018 Jun; 66(3):238-245. PubMed ID: 29795059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study).
    Belcaro G; Cornelli U; Dugall M; Hosoi M; Cotellese R; Feragalli B
    Minerva Cardioangiol; 2018 Apr; 66(2):152-159. PubMed ID: 29512362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
    Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
    J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation with Robuvit® in post-traumatic stress disorders associated to high oxidative stress.
    Belcaro G; Luzzi R; Hosoi M; Dugall M; Cesarone MR
    Minerva Med; 2018 Oct; 109(5):363-368. PubMed ID: 30338680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xerostomia and prevention of dryness with a Pycnogenol® mouth spray: a pilot study.
    Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Cotellese R
    Minerva Gastroenterol (Torino); 2024 Mar; 70(1):36-41. PubMed ID: 37162467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit®.
    Ledda A; Hosoi M; Cesarone MR; Dugall M; Hu S; Belcaro G; Maione C; Cotellese R; Feragalli B; Scipione V; Scipione C
    Panminerva Med; 2020 Sep; 62(3):131-134. PubMed ID: 32716149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.
    Cotellese R; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Hosoi M; Ippolito E; Corsi M; Luzzi R
    Panminerva Med; 2021 Sep; 63(3):343-348. PubMed ID: 34738775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengzhan Shengmai capsule versus Aspirin in the treatment of carotid atherosclerotic plaque: A single-centre, non-inferiority, prospective, randomised controlled trial.
    Shen X; Zou S; Jin J; Liu Y; Wu J; Qu L
    Phytomedicine; 2022 Nov; 106():154408. PubMed ID: 36029646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.